Recursion Pharmaceuticals (RXRX) Receivables - Other (2021 - 2026)
Recursion Pharmaceuticals (RXRX) reported Receivables - Other of $14.39 million for Q2 2026, down 33.4% from $21.61 million a year earlier but up 5.9% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Receivables - Other (2021 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals posted Receivables - Other of $24.65 million, down 49.9% from FY2024.
- Receivables - Other has a four-year compound annual growth rate of 28.4% (FY2021 to FY2025).
- By year, Receivables - Other came in at $49.17 million in FY2024, $3.09 million in FY2023 (+12.4%), $2.75 million in FY2022 (-69.6%) and $9.06 million in FY2021.
- Five-year quarterly Receivables - Other spans a low of $2.06 million in Q1 2023 and a high of $49.17 million in Q4 2024.
- Year over year, Receivables - Other has now declined in each of the last three quarters, with growth averaging 67.7% over the last six quarters.
- The high point for year-over-year Receivables - Other in five years was Q3 2022 (growth of 417.6%); the low point was Q1 2023 (a decline of 81.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.59 million (Q1 2026), $24.65 million (Q4 2025) and $21.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.39 Mn |
| Mar 31, 2026 | 13.59 Mn |
| Dec 31, 2025 | 24.65 Mn |
| Sep 30, 2025 | 21.91 Mn |
| Jun 30, 2025 | 21.61 Mn |
| Mar 31, 2025 | 46.12 Mn |
| Dec 31, 2024 | 49.17 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 11.64 Mn |
| Jun 30, 2022 | 11.66 Mn |
| Mar 31, 2022 | 11.36 Mn |
| Dec 31, 2021 | 9.06 Mn |
| Sep 30, 2021 | 2.25 Mn |
API Access
Recursion Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();